According to reports, Montenegrin pharmaceutical company Hemomont has officially opened a €5.3 million, 1,700 square meter nasal spray manufacturing facility in Podgorica that is expected to employ 30 people and produce 3 million units per month. Montenegrin President Milo Djukanovic attended the opening celebration.
Hemomont is a subsidiary of Hemofarm, which is owned by German pharmaceutical company STADA Arzneimittel. A June 2018 Hemofarm press release celebrating the company’s anniversary indicates that the new facility was constructed in an existing Hemomont plant.
Hemomont CEO Snezana Perovic is quoted as saying, “Since its inception, Hemomont has increased the number of products in its portfolio and the number of employees by seven times. The opening of the new plant for the production of SNUP indicates that Hemomont keeps growing and progressing year after year.” [Google translation]
